Abstract:Abstract Motivation Combination therapy has shown to improve therapeutic efficacy while reducing side effects. Importantly, it has become an indispensable strategy to overcome resistance in antibiotics, antimicrobials and anticancer drugs. Facing enormous chemical space and unclear design principles for small-molecule combinations, computational drug-combination design has not seen generative models to meet its potential to accelerate resistance-overcoming drug combination discovery. Results We have developed the first deep generative model for drug combination design, by jointly embedding graph-structured domain knowledge and iteratively training a reinforcement learning-based chemical graph-set designer. First, we have developed hierarchical variational graph auto-encoders trained end-to-end to jointly embed gene–gene, gene–disease and disease–disease networks. Novel attentional pooling is introduced here for learning disease representations from associated genes’ representations. Second, targeting diseases in learned representations, we have recast the drug-combination design problem as graph-set generation and developed a deep learning-based model with novel rewards. Specifically, besides chemical validity rewards, we have introduced novel generative adversarial award, being generalized sliced Wasserstein, for chemically diverse molecules with distributions similar to known drugs. We have also designed a network principle-based reward for disease-specific drug combinations. Numerical results indicate that, compared to state-of-the-art graph embedding methods, hierarchical variational graph auto-encoder learns more informative and generalizable disease representations. Results also show that the deep generative models generate drug combinations following the principle across diseases. Case studies on four diseases show that network-principled drug combinations tend to have low toxicity. The generated drug combinations collectively cover the disease module similar to FDA-approved drug combinations and could potentially suggest novel systems pharmacology strategies. Our method allows for examining and following network-based principle or hypothesis to efficiently generate disease-specific drug combinations in a vast chemical combinatorial space. Availability and implementation https://github.com/Shen-Lab/Drug-Combo-Generator. Supplementary information Supplementary data are available at Bioinformatics online.

Modeling Polypharmacy and Predicting Drug-Drug Interactions using Deep Generative Models on Multimodal Graphs

Predicting Drug-Drug Interactions using Deep Generative Models on Graphs

MAVGAE: a multimodal framework for predicting asymmetric drug–drug interactions based on variational graph autoencoder

Modeling polypharmacy side effects with graph convolutional networks

VGAEDTI: Drug-Target Interaction Prediction Based on Variational Inference and Graph Autoencoder.

Drug-target interaction prediction using semi-bipartite graph model and deep learning

UniGEN-DDI: Computing drug-drug interactions using a unified graph embedding network

Network-principled deep generative models for designing drug combinations as graph sets

Graph2MDA: a multi-modal variational graph embedding model for predicting microbe-drug associations

Prediction of drug-drug interaction events using graph neural networks based feature extraction

Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks

Polypharmacy side-effect prediction with enhanced interpretability based on graph feature attention network

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs

HyGNN: Drug-Drug Interaction Prediction via Hypergraph Neural Network

Directed graph attention networks for predicting asymmetric drug–drug interactions

Predicting Rich Drug-Drug Interactions via Biomedical Knowledge Graphs and Text Jointly Embedding

DDI Prediction via Heterogeneous Graph Attention Networks

Predicting Drug Synergy and Discovering New Drug Combinations Based on a Graph Autoencoder and Convolutional Neural Network

Prediction of multi-relational drug-gene interaction via Dynamic hyperGraph Contrastive Learning.